精神分裂症 - 新的治疗方法很快就会出现
1Division of Psychological Medicine and Clinical Neurosciences, and Neuroscience and Mental Health Innovation Institute, Cardiff University, Cardiff, UK.
The British journal of psychiatry : the journal of mental science
|November 8, 2024
概括
对精神分裂症的新疗法显示出希望. 肌肉酸乙胆固醇受体激动剂可以改善精神病和负面症状,提供超越传统多巴胺向抗精神病药物的新治疗途径.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗精神病药物主要向多巴胺受体,已经使用了70年.
- 精神分裂症的治疗仍然是一个重大的临床挑战,对负面和认知症状的需求尚未得到满足.
研究的目的:
- 审查针对精神分裂症的新兴治疗策略,即针对肌肉酸乙胆固醇受体.
- 讨论这些新型药物的潜在临床应用和预期许可.
主要方法:
- 审查最近的临床试验数据.
- 对肌肉激动剂的药理学机制的分析.
- 综合关于新型精神分裂症治疗的当前研究.
主要成果:
- 肌肉酸乙胆固醇受体的激动剂在改善精神病和负面症状方面表现出有效性.
- 这种方法代表了与传统的多巴胺受体阻塞的重大偏离.
结论:
- 肌酸乙烯基胆固醇受体激动剂为精神分裂症提供了一个有前途的新类药物.
- 这些药物预计将获得临床许可,为患者扩大治疗选择.
相关概念视频
Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
Psychosis: Goals of Pharmacotherapy
104
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
104
Psychosis and Antipsychotic Drugs: Overview
179
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
179
Antipsychotic Drugs: Therapeutic Uses and Side Effects
121
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
121
Antidepressant Drugs: MAOIs and Other Agents
195
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
195
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
473
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
473


